Publication

Papel do ómega-3 marinho nas Perturbações do Espectro do Autismo e Perturbações de Hiperatividade e Défice de Atenção - uma revisão focada na dieta das mães

Bibliographic Details
Summary:Autism Spectrum Disorders (ASD) and Attention-Deficit/Hyperactivity Disorder (ADHD) are two increasingly prevalent neurodevelopmental disorders. This rise appears to be associated with a higher dietary intake of n-6 polyunsaturated fatty acids (PUFAs) and lower of n-3 PUFAs. Docosahexaenoic acid (DHA), a key nutritional n-3 PUFA, is crucial for an optimal offspring's neurodevelopment through the last trimester of pregnancy. Recently, lower DHA levels have been reported in children with ASD and ADHD. The present review summarizes the main research achievements concerning the effect of maternal DHA intake in children neurodevelopment, in order to elicit its role in the prevention and mitigation of ASD and ADHD. As main finding, a low maternal marine DHA intake seems negatively affect childhood neurodevelopment. Although higher DHA status at delivery were associated with better childhood neurodevelopmental, controversial results found in prenatal supplementation raised the hypothesis that the benefits of DHA may be influenced by other factors as socio-economic background and life-style. Low maternal DHA intake, conversely appears to raise the risk and the severity of ASD or ADHD. In conclusion, an optimal maternal consumption of marine products and being breastfeed may promote some neuronal protection in offspring, confirming the essential role of DHA as a modifiable risk factor for ASD and ADHD.
Subject:Medicina clínica Clinical medicine
Country:Portugal
Document type:master thesis
Access type:Open
Associated institution:Repositório Aberto da Universidade do Porto
Language:Portuguese
Origin:Repositório Aberto da Universidade do Porto
_version_ 1850560647449804800
conditionsOfAccess_str open access
country_str PT
description Autism Spectrum Disorders (ASD) and Attention-Deficit/Hyperactivity Disorder (ADHD) are two increasingly prevalent neurodevelopmental disorders. This rise appears to be associated with a higher dietary intake of n-6 polyunsaturated fatty acids (PUFAs) and lower of n-3 PUFAs. Docosahexaenoic acid (DHA), a key nutritional n-3 PUFA, is crucial for an optimal offspring's neurodevelopment through the last trimester of pregnancy. Recently, lower DHA levels have been reported in children with ASD and ADHD. The present review summarizes the main research achievements concerning the effect of maternal DHA intake in children neurodevelopment, in order to elicit its role in the prevention and mitigation of ASD and ADHD. As main finding, a low maternal marine DHA intake seems negatively affect childhood neurodevelopment. Although higher DHA status at delivery were associated with better childhood neurodevelopmental, controversial results found in prenatal supplementation raised the hypothesis that the benefits of DHA may be influenced by other factors as socio-economic background and life-style. Low maternal DHA intake, conversely appears to raise the risk and the severity of ASD or ADHD. In conclusion, an optimal maternal consumption of marine products and being breastfeed may promote some neuronal protection in offspring, confirming the essential role of DHA as a modifiable risk factor for ASD and ADHD.
documentTypeURL_str http://purl.org/coar/resource_type/c_bdcc
documentType_str master thesis
id 89fea179-55aa-4b45-b4b3-6909b412003d
identifierHandle_str https://hdl.handle.net/10216/114306
language por
relatedInstitutions_str_mv Repositório Aberto da Universidade do Porto
resourceName_str Repositório Aberto da Universidade do Porto
spellingShingle Papel do ómega-3 marinho nas Perturbações do Espectro do Autismo e Perturbações de Hiperatividade e Défice de Atenção - uma revisão focada na dieta das mães
Medicina clínica
Clinical medicine
title Papel do ómega-3 marinho nas Perturbações do Espectro do Autismo e Perturbações de Hiperatividade e Défice de Atenção - uma revisão focada na dieta das mães
topic Medicina clínica
Clinical medicine